A day-to-day management model improves patient compliance to treatment for Helicobacter pylori infection: a prospective, randomized controlled study

被引：0
|
作者：
Zhen Yang
Wenjie Xiong
Ruoyun Yang
Haisheng Qian
Zhi He
Meihong Chen
Jiajia Yang
Huaiming Sang
Jin Yan
Xiaobing Xu
Yun Wang
Guoxin Zhang
Feng Ye
机构：
[1] First Affiliated Hospital of Nanjing Medical University,Department of Gastroenterology
[2] First Clinical Medical College of Nanjing Medical University,undefined
来源：
Gut Pathogens | / 15卷
关键词：
infection; Day-to-day; Conventional outpatient education; Habit formation; Compliance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 34 条
  • [21] Pretreatment with Ranitidine Bismuth Citrate May Improve Success Rates of Helicobacter pylori Eradication: A Prospective, Randomized, Controlled and Open-Label Study
    Yoon, Jin Young
    Kwak, Min Seob
    Jeon, Jung Won
    Cha, Jae Myung
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 255 (01) : 41 - 48
  • [22] Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial
    Bi, Hanxin
    Chen, Xingxing
    Chen, Yuxin
    Zhao, Xin
    Wang, Shasha
    Wang, Jiehong
    Lyu, Ting
    Han, Shuang
    Lin, Tao
    Li, Mingquan
    Yuan, Donghong
    Liu, Junye
    Shi, Yongquan
    CHINESE MEDICAL JOURNAL, 2022, 135 (14) : 1707 - 1715
  • [23] Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study
    Navarro-Rodriguez, Tomas
    Silva, Fernando Marcuz
    Barbuti, Ricardo Correa
    Mattar, Rejane
    Moraes-Filho, Joaquim Prado
    de Oliveira, Marice Nogueira
    Bogsan, Cristina S.
    Chinzon, Decio
    Eisig, Jaime Natan
    BMC GASTROENTEROLOGY, 2013, 13
  • [24] Compliance with 14-day primaquine therapy for radical cure of vivax malaria - a randomized placebo-controlled trial comparing unsupervised with supervised treatment
    Leslie, T
    Rab, MA
    Ahmadzai, H
    Durrani, N
    Fayaz, M
    Kolaczinski, J
    Rowland, M
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2004, 98 (03) : 168 - 173
  • [25] Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naive or for retreatment of Helicobacter pylori. Two randomized pilot studies
    Dore, Maria Pina
    Bibbo, Stefano
    Loria, Mariafrancesca
    Salis, Roberta
    Manca, Alessandra
    Pes, Giovanni Mario
    Graham, David Yates
    HELICOBACTER, 2019, 24 (06)
  • [26] 10-Day Versus 14-Day Quadruple Concomitant Nonbismuth Therapy for the Treatment ofHelicobacter pyloriInfection Results From a Randomized Prospective Study in a High Clarithromycin Resistance Country
    Apostolopoulos, Periklis
    Ekmektzoglou, Konstantinos
    Georgopoulos, Sotirios
    Chounta, Eleni
    Theofanopoulou, Antonia
    Kalantzis, Chrisostomos
    Vlachou, Erasmia
    Tsibouris, Panagiotis
    Alexandrakis, Georgios
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2020, 54 (06) : 522 - 527
  • [27] 14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial
    Liou, Jyh-Ming
    Chen, Chieh-Chang
    Fang, Yu-Jen
    Chen, Po-Yueh
    Chang, Chi-Yang
    Chou, Chu-Kuang
    Chen, Mei-Jyh
    Tseng, Cheng-Hao
    Lee, Ji-Yuh
    Yang, Tsung-Hua
    Chiu, Min-Chin
    Yu, Jian-Jyun
    Kuo, Chia-Chi
    Luo, Jiing-Chyuan
    Hsu, Wen-Feng
    Hu, Wen-Hao
    Tsai, Min-Horn
    Lin, Jaw-Town
    Shun, Chia-Tung
    Twu, Gary
    Lee, Yi-Chia
    Bair, Ming-Jong
    Wu, Ming-Shiang
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2510 - 2518
  • [28] Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial
    Yang, Chenghai
    Liang, Liping
    Lv, Pinjing
    Liu, Le
    Wang, Siqi
    Wang, Zhiqing
    Chen, Ye
    HELICOBACTER, 2021, 26 (06)
  • [29] A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial
    Tai, Wei-Chen
    Liang, Chih-Ming
    Kuo, Chung-Mou
    Huang, Pao-Yuan
    Wu, Cheng-Kun
    Yang, Shih-Cheng
    Kuo, Yuan-Hung
    Lin, Ming-Tsung
    Lee, Chen-Hsiang
    Hsu, Chien-Ning
    Wu, Keng-Liang
    Hu, Tsung-Hui
    Chuah, Seng-Kee
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (06) : 1718 - 1724
  • [30] Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study
    Wang, Tongyu
    Yang, Xiaoxiao
    Li, Yueyue
    Li, Lixiang
    Liu, Jing
    Ji, Chaoran
    Sun, Yiyuan
    Li, Yanqing
    Zuo, Xiuli
    HELICOBACTER, 2019, 24 (03)
1234